Ahmed Rana, Borst Jacqueline, Wei Yong C, Aslani Parisa
1 University of Sydney, NSW, Australia.
2 University of Utrecht, The Netherlands.
J Atten Disord. 2017 Jan;21(2):91-99. doi: 10.1177/1087054713499231. Epub 2016 Jul 28.
The aim of the present study was to explore factors influencing parents' decisions to adhere and persist with ADHD pharmacotherapy in children.
Focus groups ( n = 3) were conducted with 16 parents recruited from metropolitan Sydney. Group discussions explored factors impacting on treatment initiation, continuation, and cessation. Focus groups were audio-recorded, transcribed verbatim, and thematically content analyzed.
Parents commenced and continued pharmacotherapy due to its positive impact on their child's behavior. Improvements in the child's academic performance and social interactions encouraged persistence with therapy. Parents elected to cease therapy after their children experienced side effects including appetite suppression, weight loss, and sleep disturbances. Concerns about long-term effects of ADHD medication use including potential for addiction and growth stunting, in addition to the stigma surrounding ADHD also contributed to parents ceasing treatment.
The findings highlight a need for the provision of accurate information about ADHD and its treatments to parents to empower their treatment decisions and promote adherence.
本研究旨在探讨影响父母决定让孩子坚持接受注意力缺陷多动障碍(ADHD)药物治疗的因素。
对从悉尼大都市招募的16名家长进行了焦点小组访谈(共3组)。小组讨论探讨了影响治疗开始、持续和停止的因素。焦点小组访谈进行了录音,逐字转录,并进行了主题内容分析。
父母开始并持续进行药物治疗是因为其对孩子行为有积极影响。孩子学业成绩和社交互动的改善促使他们坚持治疗。在孩子出现包括食欲抑制、体重减轻和睡眠障碍等副作用后,父母选择停止治疗。对ADHD药物使用的长期影响的担忧,包括成瘾和生长发育迟缓的可能性,以及围绕ADHD的污名化,也促使父母停止治疗。
研究结果凸显了向父母提供有关ADHD及其治疗的准确信息的必要性,以增强他们的治疗决策能力并促进依从性。